Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its position in Danaher Corporation (NYSE:DHR – Free Report) by 4.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 146,228 shares of the conglomerate’s stock after selling 6,808 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Danaher were worth $33,475,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth approximately $26,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher in the third quarter worth approximately $27,000. Finally, Financial Life Planners bought a new position in shares of Danaher in the third quarter worth approximately $32,000. Institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
DHR has been the topic of several analyst reports. Citigroup initiated coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. Wells Fargo & Company decreased their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Wolfe Research decreased their price objective on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a report on Wednesday, April 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average price target of $238.24.
Danaher Stock Up 0.0%
DHR opened at $182.73 on Monday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a 50 day moving average price of $182.11 and a 200-day moving average price of $207.45. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market capitalization of $129.33 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.44 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the company earned $1.88 earnings per share. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
